Better Therapeutics, Inc.
BTTX
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -31.57M | -37.12M | -39.46M | -39.76M | -44.89M |
| Total Depreciation and Amortization | 438.00K | 291.00K | 145.00K | 53.00K | 1.04M |
| Total Amortization of Deferred Charges | 2.68M | 2.68M | 2.68M | 2.68M | 1.52M |
| Total Other Non-Cash Items | 1.76M | 1.95M | 1.87M | 1.83M | 3.56M |
| Change in Net Operating Assets | 612.00K | 5.05M | 5.98M | 6.27M | 330.00K |
| Cash from Operations | -26.08M | -27.15M | -28.79M | -28.93M | -38.44M |
| Capital Expenditure | -45.00K | -63.00K | -93.00K | -106.00K | -129.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.27M | -1.70M | -1.57M | -1.07M | -1.16M |
| Cash from Investing | -1.32M | -1.76M | -1.66M | -1.18M | -1.29M |
| Total Debt Issued | 0.00 | 0.00 | 5.00M | 5.00M | 15.00M |
| Total Debt Repaid | -858.00K | -858.00K | -435.00K | -- | -- |
| Issuance of Common Stock | 13.40M | 6.68M | 283.00K | 284.00K | 153.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -844.00K | -400.00K | -- | -- | 43.66M |
| Cash from Financing | 11.69M | 5.42M | 4.85M | 5.28M | 58.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.71M | -23.49M | -25.61M | -24.83M | 19.07M |